Novaptech

Pessac, France Founded: 2008 • Age: 18 yrs
Aptamers screening tools and services are developed and offered.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Novaptech

Novaptech is a company based in Pessac (France) founded in 2008. Novaptech offers products and services including Custom Aptamer Selection, Aptamer-based Assays, and Rapid Tests. Novaptech operates in a competitive market with competitors including Aptamer Group, Femtogenix, Aptus Biotech, Aptamer Sciences and Archemix, among others.

  • Headquarter Pessac, France
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Novaptech

Novaptech offers a comprehensive portfolio of products and services, including Custom Aptamer Selection, Aptamer-based Assays, and Rapid Tests.

Product name locked
Category locked
Primary

Service for identifying aptamers that bind to specific targets with high affinity.

Product name locked
Category locked
Locked

Develops assays for detecting biomarkers and pathogens in various samples.

Product name locked
Category locked
Locked

Creates point-of-care tests for quick environmental and clinical detection.

Funding Insights of Novaptech

Investors in Novaptech

Novaptech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bpifrance.

All
Institutional
Investor Description Founded Year Domain Location
Corporate consultancy, advisory, and funding services are provided to businesses.
Locked Locked Locked
Premium access

Investor details for Novaptech

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Novaptech

Investments
Premium access

Investment portfolio details for Novaptech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Novaptech

Premium access

Detailed financials for Novaptech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Novaptech Comparisons

Novaptech Primary company
Description
Aptamers screening tools and services are developed and offe...
Location
Pessac, France
Founded Year
2008
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Novaptech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Novaptech

Novaptech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aptamer Group, Femtogenix, Aptus Biotech, Aptamer Sciences and Archemix, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Manufacturer of DNA and RNA nucleic acid aptamers for use in research & development
Locked Locked Locked
DNA-interactive payload molecules for ADCs are developed by Femtogenix.
Locked Locked Locked
Aptamer-based biotechnological applications are developed for diverse uses.
Locked Locked Locked
Proprietary aptamer technology is utilized for protein analysis.
Locked Locked Locked
Develops aptamer therapeutics for rare hematological diseases.
Locked Locked Locked
Services for custom aptamer development
Premium access

Detailed competitors of Novaptech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Novaptech

Premium access

Complete news archive for Novaptech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Novaptech

Novaptech was founded in 2008 and raised its 1st funding round 8 years after it was founded.

Novaptech is headquartered in Pessac, France. It is registered at Pessac, Gironde, France.

Novaptech was established in 2008 in Pessac, France, within the biotechnology sector. An automated platform is utilized by the company to identify and characterize aptamers, with services extended to universities and private laboratories for aptamer production. Partnerships with public and private organizations are maintained to advance aptamer-based imaging probes, monitoring devices, and biosensors.

Novaptech's top competitors include Aptamer Group, Aptamer Sciences and Base Pair Biotechnologies.

Novaptech offers Custom Aptamer Selection, Aptamer-based Assays, and Rapid Tests.

Novaptech has 1 investor. Key investors include Bpifrance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available